4.6 Article

Dual-functional coating that inhibits bone resorption and promotes bone formation applied to the surface modification of titanium screws

Related references

Note: Only part of the references are listed.
Review Obstetrics & Gynecology

Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk

Sian Yik Lim

Summary: Increased understanding of the Wnt signaling pathway has led to the development of romosozumab, one of the most potent osteoanabolic agents for osteoporosis treatment. Romosozumab inhibits sclerostin, activating the Wnt signaling pathway and promoting bone formation and reducing bone resorption.

WOMENS HEALTH (2022)

Article Medicine, General & Internal

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

F. Cosman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Postmenopausal osteoporosis

Richard Eastell et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Biotechnology & Applied Microbiology

Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis

E. Michael Lewiecki

EXPERT OPINION ON BIOLOGICAL THERAPY (2011)